Zhe Wang

Zhe Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SDShuang Dong
Shuang Dong
ZWZhe Wang
Zhe Wang
BHBinbin Huang
Binbin Huang
JZJunjie Zhang
Junjie Zhang
YGYanli Ge
Yanli Ge
ZWZhirong Wang
Zhirong Wang

16 September 2022 in Journal of Oncology
Verified
Journal Article
Open access
LFLiu Fu
Liu Fu
ZWZhe Wang
Zhe Wang
FJFengxiang Jiang
Fengxiang Jiang
GWGuohua Wei
Guohua Wei
LSLonge Sun
Longe Sun
JZJianhuan Zhu
Jianhuan Zhu
High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer: Objective. Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) is involved in the occurrence and development of various tumors. However, the effect of EIF4G2 in gastric cancer (GC) has not been fully explored. The purpose of this study was to explore the function and mechanism of EIF4G2 in GC. Methods. The Tumor Immune Estimation Resource 2.0 database was used to analyze EIF4G2 expression in various cancers and the relationship between EIF4G2 expression and tumor-infiltrating immune cells. Gene Expression Profiling Interactive Analysis was utilized to assess the EIF4G2 expression level and its effect on survival in GC. UALCAN was conducted to analyze EIF4G2 expression in various subgroups of GC. The KaplanMeier plotter was employed for survival analysis. Receiver operator characteristic (ROC) curve analysis was applied to evaluate the diagnostic role of EIF4G2 in GC. LinkedOmics was used to identify the co-expressed genes and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways. The Tumor-Immune System Interaction database was employed to analyze the correlation between EIF4G2 expression and tumor-infiltrating lymphocytes. The starBase web platform was used to predict the upstream microRNAs and long noncoding RNAs. Results. EIF4G2 expression was upregulated in GC tissues compared to normal controls. High expression of EIF4G2 indicated poor prognosis in GC. ROC analysis revealed that EIF4G2 had good diagnostic ability to distinguish GC from normal tissues. Immune infiltration analysis indicated that EIF4G2 expression may be involved in the modulation of tumor immune infiltration in GC. Finally, we determined that the Taurine Upregulated 1 (TUG1)/hsa-miR-26a-5p/EIF4G2 axis was the most likely regulatory pathway involved in GC development. Conclusions. EIF4G2 was upregulated in GC and elevated expression of EIF4G2 indicated unfavorable prognosis. Moreover, EIF4G2 expression may be involved in the regulation of tumor immune cell infiltration. The TUG1/hsa-miR-26a-5p axis is a likely upstream regulatory mechanism of EIF4G2 in GC. EIF4G2 may thus serve as a prognosis biomarker and present a new therapeutic target.

17 February 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YSYingying Sun
Yingying Sun
YGYanli Ge
Yanli Ge
ZXZhiyu Xia
Zhiyu Xia
CGCheng Guo
Cheng Guo
JZJunjie Zhang
Junjie Zhang
ZWZhe Wang
Zhe Wang
Introduction: Gastric cancer (GC) is the fifth most common malignancy worldwide, with metastasis being the primary cause of mortality. Although circular RNAs (circRNAs) are implicated in GC pathogenesis, their specific roles in metastasis remain unclear. This study was designed to investigate the functional significance and underlying molecular mechanisms of circNF1 in GC metastasis. Methods: The expression of circNF1 was assessed in GC tissues and paired adjacent normal tissues using in situ hybridization, and its clinical relevance was evaluated via Cox regression analysis. Functional characterization was performed using transwell migration assays and in vivo metastatic mouse models to determine the effects of circNF1 overexpression or knockdown on GC cell motility and lung metastasis. Mechanistic investigations included molecular interaction studies to explore the association between circNF1 and IGF2BP1, as well as transcriptional regulation assays to identify the upstream regulator of circNF1 biogenesis. Results: Overexpression of circNF1 significantly enhanced GC cell migration in vitro and lung metastasis in vivo, whereas knockdown of circNF1 suppressed these metastatic phenotypes. Mechanistically, circNF1 was found to interact directly with IGF2BP1, thereby stabilizing HMGA2 mRNA and promoting its expression. Furthermore, ZNF460 was identified as a transcriptional activator of the NF1 host gene, which in turn upregulated circNF1 expression. Discussion: Our findings demonstrate that ZNF460-mediated upregulation of circNF1 drives GC metastasis by acting as a molecular scaffold to interact with IGF2BP1 and stabilize HMGA2 mRNA. This study not only elucidates a novel regulatory axis in GC metastasis but also identifies circNF1 as a promising prognostic biomarker and potential therapeutic target for the treatment of metastatic GC.

9 November 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YSYingying Sun
Yingying Sun
YGYanli Ge
Yanli Ge
ZXZhiyu Xia
Zhiyu Xia
CGCheng Guo
Cheng Guo
JZJunjie Zhang
Junjie Zhang
ZWZhe Wang
Zhe Wang

17 February 2026 in PLOS ONE
Verified
Journal Article
Open access
WZWuqian Zhang
Wuqian Zhang
YWYujing Wang
Yujing Wang
QCQunyou Cong
Qunyou Cong
XTXiaoshun Tang
Xiaoshun Tang
ZWZhe Wang
Zhe Wang
ZWZhirong Wang
Zhirong Wang
Background: Metabolic-associated fatty liver disease (MAFLD), a disease closely associated with metabolic abnormalities (e.g., insulin resistance, dyslipidemia, elevated blood glucose, and obesity), has become a global public health challenge. This study explored the independent associations between sedentary behavior and depressive symptoms with MAFLD and analyzed the potential interactions between these two factors and the risk of MAFLD occurrence. Methods: This cross-sectional study is based on data from two cycles of the National Health and Nutrition Examination Survey (NHANES) from 2017 ~ 2020 and 2021 ~ 2023 and analyzes the relationships among depressive symptoms, sedentary behavior, potential confounding factors, and MAFLD. A multivariate logistic regression model was used in the present study, and different subgroups of sedentary behavior were analyzed to assess the associations among sedentary behavior, depression and MAFLD. In addition, the presence of additive interactions among these variables was assessed by calculating the relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S). Results: A total of 10,612 participants were included in this study (weighted sample size of 183,231,593), of whom 4,501 (weighted proportion of 42%) had MAFLD. Compared with participants with less daily sedentary time, those with more sedentary time had a greater risk of MAFLD (OR = 1.33, 95% CI: 1.08 ~ 1.64). We also found that, compared with individuals without depressive symptoms, individuals with depressive symptoms were significantly associated with an increased risk of MAFLD (OR = 1.26, 95% CI: 1.03 ~ 1.54). Furthermore, sedentary behavior significantly interacted with depression in overweight individuals, affecting the risk of MAFLD (relative excess risk (RERI) = 0.684, 95% CI: 0.312 ~ 1.057; attributable proportion (AP) = 0.360, 95% CI: 0.323 ~ 0.397; synergy index (S) = 1.623, 95% CI: 1.177 ~ 2.070). Poisson regression with 90% CI confirmed this interaction (RERI = 0.318, 90% CI: 0.036 ~ 0.600; AP = 0.223, 90% CI: 0.182 ~ 0.263; S=1.310, 90% CI: 1.000 ~ 1.620). Conclusion: Sedentary behavior and depression have a significant synergistic effect on MAFLD in overweight individuals. Therefore, improving individuals’ psychological health status and reducing sedentary time may have positive effects on the prevention and treatment of MAFLD.